(firstQuint)Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.

09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.

1% Following Selective Laser Trabeculoplasty (SLT).

 Open label, single armed, cross over controlled study to evaluate comfort and IOP (Intraocular Pressure) changes of specific NSAIDs post SLT.

 Patients (n= 25, total 50 eyes) scheduled to undergo bilateral Selective Laser Trabeculoplasty (SLT) will instill bromfenac in the first eye to undergo SLT, and the contra lateral eye will receive nepafenac.

.

 Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.

09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.

1% Following Selective Laser Trabeculoplasty (SLT)@highlight

The objective of this study is to evaluate and compare the comfort of bromfenac or nepafenac following SLT.

